Trial Profile
Randomized Single Dose Multiple Crossover Relative Bioavailability Trial of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs BILR 355 BS (Primary) ; Ritonavir; Sodium lauril-sulfate
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 14 Oct 2014 New trial record